Latest Shareholder Disclosures News

Page 1 of 1
Microba Life Sciences has been suspended from trading after revised terms for its proposed Genetic Signatures merger left it unable to complete the second tranche of its institutional placement. The company says it is assessing alternative funding while its cashflow runway narrows.
Victor Sage
Victor Sage
17 Nov 2026
BCAL Diagnostics, an 18.46% shareholder of Genetic Signatures, has asked the Takeovers Panel to intervene over the proposed merger with Microba Life Sciences. The application alleges the deal structure and shareholder process lack adequate protections, although no Panel has yet been appointed and no decision has been made.
Ada Torres
Ada Torres
13 Nov 2026
The Australian Takeovers Panel has declared unacceptable circumstances in A2MP Investments’ lapsed A$0.05-a-share takeover bid for Canyon Resources, citing inadequate disclosure, the use of confidential information and potential coercion of shareholders. Final orders remain undecided.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Pengana International Equities (ASX: PIA) confirms it will proceed with an off-market equal access buy-back following shareholder approval, setting a record date of 7 August 2026. The buy-back faces legal challenges from Pengana Capital Limited but remains on track unless a court intervenes.
Claire Turing
Claire Turing
3 Aug 2026
The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.
Ada Torres
Ada Torres
1 May 2026
Kjerulf David Hastings Ainsworth has issued a first supplementary statement for his second off-market takeover bid targeting 5.5% of Ainsworth Game Technology shares at $1.30 each, revealing an 8.24% voting stake ahead of the offer’s close.
Victor Sage
Victor Sage
30 Mar 2026
BSP Financial Group has explained the late filing of a director’s shareholding change, attributing it to delayed confirmation from a financial advisor, while reaffirming its compliance policies.
Claire Turing
Claire Turing
8 Dec 2025
Macarthur Minerals has updated its rights issue prospectus, introducing a cap on the underwriter's shareholding and revising key offer terms. These changes aim to balance funding needs with shareholder control and regulatory compliance.
Maxwell Dee
Maxwell Dee
23 July 2025

Browse the archive

Full archive